Literature DB >> 7722415

Phenotypic and functional heterogeneity of the murine alveolar macrophage-derived cell line MH-S.

K Sankaran1, H B Herscowitz.   

Abstract

We have previously reported that MH-S, an established murine alveolar macrophage-derived cell line, mediated profound inhibition of in vitro antibody production, as did their freshly isolated alveolar macrophage (AM) counterparts. In this communication we show that like freshly recovered AMs, the MH-S cell line also displays phenotypic and functional heterogeneity. Sorting of parental MH-S cells by flow cytometry based on reactivity with anti-Mac-1 antibody yielded two subsets. Further analysis by staining with monoclonal antibodies against well-characterized murine macrophage cell surface markers revealed that both Mac-1+ and Mac-1- subsets expressed the mature murine macrophage antigen (F4/80) and class II major histocompatibility complex molecules, but with different intensity. In contrast, the two subsets stained equivalently with antibody against the Fc gamma II receptor, whereas neither subset stained with anti-CD4 antibody. Examination by light microscopy revealed plemorphism in the Mac-1+ population with many of the cells appearing spindle shaped and having elongated processes, whereas a majority of the cells in the Mac-1- population were spherical in shape. Functionally, cells from the Mac-1+ population were less inhibitory of in vitro antibody production and produced significantly more nitric oxide in response to stimulation with lipopolysaccharide than were cells in the Mac-1- population. Essentially similar results were obtained using cloned Mac-1+ and Mac-1- MH-S cells. The finding of heterogeneity in an established cell line that displays functions similar to those of freshly recovered AMs suggests that distinct subsets of AMs may be involved in the pathogenesis of disease processes in the lung.

Entities:  

Mesh:

Year:  1995        PMID: 7722415     DOI: 10.1002/jlb.57.4.562

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Immortalized MH-S cells lack defining features of primary alveolar macrophages and do not support mouse pneumovirus replication.

Authors:  Todd A Brenner; Tyler A Rice; Erik D Anderson; Caroline M Percopo; Helene F Rosenberg
Journal:  Immunol Lett       Date:  2016-02-23       Impact factor: 3.685

2.  Phosphodiesterase 2A is a major negative regulator of iNOS expression in lipopolysaccharide-treated mouse alveolar macrophages.

Authors:  Otgonchimeg Rentsendorj; Franco R D'Alessio; David B Pearse
Journal:  J Leukoc Biol       Date:  2014-07-25       Impact factor: 4.962

3.  Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis.

Authors:  Jiong Deng; Junya Fujimoto; Xiao-Feng Ye; Tao-Yan Men; Carolyn S Van Pelt; Yu-Long Chen; Xiao-Feng Lin; Humam Kadara; Qingguo Tao; Dafna Lotan; Reuben Lotan
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-30

4.  Regulation of ICAM-1 expression in mouse macrophages.

Authors:  A K Hubbard; C Giardina
Journal:  Inflammation       Date:  2000-04       Impact factor: 4.092

5.  The Vsa shield of Mycoplasma pulmonis is antiphagocytic.

Authors:  Brandon M Shaw; Warren L Simmons; Kevin Dybvig
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

6.  Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production.

Authors:  Mairi C Noverr; Gary M Cox; John R Perfect; Gary B Huffnagle
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

7.  Ron receptor tyrosine kinase negatively regulates TNFalpha production in alveolar macrophages by inhibiting NF-kappaB activity and Adam17 production.

Authors:  Nikolaos M Nikolaidis; Jerilyn K Gray; Devikala Gurusamy; William Fox; William D Stuart; Nathan Huber; Susan E Waltz
Journal:  Shock       Date:  2010-02       Impact factor: 3.454

8.  EPS-I polysaccharide protects Mycoplasma pulmonis from phagocytosis.

Authors:  Brandon M Shaw; James M Daubenspeck; Warren L Simmons; Kevin Dybvig
Journal:  FEMS Microbiol Lett       Date:  2012-11-28       Impact factor: 2.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.